Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio Market Cap : 385.51M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 385.51M |
| September 24, 2026 | 396.96M |
| September 23, 2026 | 413.18M |
| September 22, 2026 | 430.36M |
| September 21, 2026 | 429.40M |
| September 18, 2026 | 425.58M |
| September 17, 2026 | 436.08M |
| September 16, 2026 | 439.90M |
| September 15, 2026 | 470.43M |
| September 14, 2026 | 497.15M |
| September 11, 2026 | 497.15M |
| September 10, 2026 | 513.37M |
| September 09, 2026 | 544.86M |
| September 08, 2026 | 584.94M |
| September 04, 2026 | 594.48M |
| September 03, 2026 | 561.08M |
| September 02, 2026 | 541.05M |
| September 01, 2026 | 539.14M |
| August 31, 2026 | 528.64M |
| August 28, 2026 | 545.82M |
| August 27, 2026 | 558.22M |
| August 26, 2026 | 571.58M |
| August 25, 2026 | 603.07M |
| August 24, 2026 | 601.16M |
| August 21, 2026 | 558.22M |
| Date | Value |
|---|---|
| August 20, 2026 | 548.68M |
| August 19, 2026 | 557.27M |
| August 18, 2026 | 550.59M |
| August 17, 2026 | 542.00M |
| August 14, 2026 | 531.50M |
| August 13, 2026 | 537.23M |
| August 12, 2026 | 551.54M |
| August 11, 2026 | 530.55M |
| August 10, 2026 | 537.23M |
| August 07, 2026 | 569.20M |
| August 06, 2026 | 544.86M |
| August 05, 2026 | 535.13M |
| August 04, 2026 | 539.87M |
| August 03, 2026 | 523.74M |
| July 31, 2026 | 515.20M |
| July 30, 2026 | 525.64M |
| July 29, 2026 | 503.82M |
| July 28, 2026 | 525.64M |
| July 27, 2026 | 510.46M |
| July 24, 2026 | 496.23M |
| July 23, 2026 | 501.92M |
| July 22, 2026 | 512.36M |
| July 21, 2026 | 538.92M |
| July 20, 2026 | 499.07M |
| July 17, 2026 | 517.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.5062M |
| Brainstorm Cell Therapeutics, Inc. | 10.70M |
| Summit Therapeutics, Inc. | 12.38B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 193.80M |
Market Cap Related Metrics
| PEG Ratio | -0.0488 |
| Price to Book Value | 1.956 |
| Price | 4.04 |
| Earnings Yield | -31.14% |
| PEGY Ratio | -0.0488 |